Home › NDC Lookup › Ingredients › Niccolum Sulphuricum, Kali Bromatum, Zin... › 61480-0145-63
⚪image loading
(from DailyMed)

ACNE Niccolum Sulphuricum, Kali Bromatum, Zincum Oxydatum, Hepar Sulphuris Calcareum, Sulphur. 3 [hp_X]/1; 1 [hp_X]/1; 1 [hp_X]/1; 3 [hp_X]/1; 1 [hp_X]/1 Tablet, Chewable

by PLYMOUTH HEALTHCARE PRODUCTS LLC · 3 BLISTER PACK in 1 BOX (61480-145-63) / 20 TABLET, CHEWABLE in 1 BLISTER PACK
NDC 61480-0145-63
🏷️ FDA NDC (as labeled) 61480-145-63 billing pads the product segment with a zero
OTC On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 61480-145-63
Product NDC 61480-145
11-digit billing NDC 61480014563
UNII JC9WZ4FK68, OSD78555ZM, SOI2LOH54Z, 1MBW07J51Q, 70FD1KFU70
SPL Set ID 6cdd54fa-6997-48da-8209-86e530f83c61
Established class (EPC) Copper Absorption Inhibitor
Physiologic effect Decreased Copper Ion Absorption
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-05-01
Route ORAL
Dosage form TABLET, CHEWABLE
Substance NICKEL SULFATE HEXAHYDRATE; POTASSIUM BROMIDE; ZINC OXIDE; CALCIUM SULFIDE; SULFUR
Why two NDCs? The FDA registers this code as 61480-145-63 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 61480-0145-63. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerPLYMOUTH HEALTHCARE PRODUCTS LLC
Labeler code61480
First marketedMay 2016
Product typeHuman Otc Drug
Portfolio7 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is a chewable tablet formulated according to homeopathic tradition and marketed as an unapproved homeopathic product for acne. The tablet contains five homeopathic ingredients: nickel sulfate, potassium bromide, sulfur, zinc oxide, and calcium sulfide, all prepared at homeopathic potencies. In homeopathic practice, these substances are traditionally used to address skin conditions, though homeopathic products are not evaluated by the FDA for effectiveness and their clinical benefit is not established by standard medical evidence.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Acne 3 [hp_X]/1; 1 [hp_X]/1; 1 [hp_X]/1; 3 [hp_X]/1; 1 [hp_X]this 61480-0145-63 PLYMOUTH 20 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2016
On the market since
May 2016
📍
2026
Currently FDA-listed
10 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Acne (this brand).

Top reported reactions

Back Pain1
Muscle Tightness1
Nasopharyngitis1
Pruritus1
Rash Erythematous1
Tooth Disorder1

Reporter sex

4 reports
Male · 33%
Female · 67%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
61480-0145-63 You're viewing this 3 BLISTER PACK in 1 BOX (61480-145-63) / 20 TABLET, CHEWABLE in 1 BLISTER PACK 2016-05-01 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing

About homeopathic listings

ACNE Niccolum Sulphuricum, Kali Bromatum, Zincum Oxydatum, Hepar Sulphuris Calcareum, Sulphur. 3 [hp_X]/1; 1 [hp_X]/1; 1 [hp_X]/1; 3 [hp_X]/1; 1 [hp_X]/1 TABLET, CHEWABLE is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 61480-145-63, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 61480-0145-63, written without dashes as 61480014563. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 61480-0145-63, the first segment (61480) is the labeler code FDA assigned to PLYMOUTH HEALTHCARE PRODUCTS LLC; the middle segment (0145) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (63) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by PLYMOUTH HEALTHCARE PRODUCTS LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
PLYMOUTH HEALTHCARE PRODUCTS LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 28 words ▾

Uses: For the temporary relief of Acne, Rosacea symptoms. **The claims for this product are based upon traditional homeopathic practice. They have not been reviewed by the FDA.

⏱️ Dosage and Administration 109 words ▾

Directions: Adults & Children 50 lbs & Up: Take ONCE per day as indicated on the chart below according to your weight: Weight Daily Dosage 50 - 100 lbs ....................... (1) Pills Daily 100 - 150 lbs ..................... (2) Pills Daily 150 - 200 lbs .....................

(3) Pills Daily Over 200 lbs ...................... (4) Pills Daily Chew pill & allow to dissolve in the mouth for 1-2 minutes before swallowing. Do not eat or drink anything for 10 minutes after swallowing for maximum effectiveness. ​ Recommended treatment course: 2-4 weeks.

Continue using as long as beneficial. Increase dosage by 50% if symptoms do not improve after 1 week. ​

⚠️ Warnings 114 words ▾

Warnings: DO NOT USE if you have kidney disease in children under 10 years old children under 50 lbs if pregnant Ask a doctor before use if you have a known sensitivity to nickel or costume jewelry a known sensitivity to any ingredients in this product Stop use and ask a doctor if skin rash appears feelings of nervousness occur if condition worsens or does not improve after regular use of this product ​If pregnant, ​​do not use. ​ If breast-feeding , ask a doctor before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Keep out of reach of children.

🧪 Active Ingredient 66 words ▾

Drug Facts Active ingredients (HPUS*) in each 600mg pill Purpose** Niccolum Sulphuricum 3X HPUS Pimples, Itching Kali Bromatum 1X HPUS Acne Simplex Zincum Oxydatum 1X HPUS Acne Treatment Hepar Sulphuris Calcareum 3X HPUS Eruption of Pimples Sulphur 1X HPUS Skin Eruptions, Inflammation *The letters "HPUS" indicate that these ingredients are officially monographed in the Homeopathic Pharmacopoeia of the United States. 1X and 3X are homeopathic dilutions.

🧪 Inactive Ingredients 9 words ▾

Inactive ingredients: Magnesium Stearate, Maltodextrin, Natural Blueberry Flavor, Sucrose.

🎯 Purpose 10 words ▾

Relieves Acne Symptoms: Adult/Teen Back/Body Hormonal Rosacea Promotes Skin Health

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 61480-0137-05 · PLYMOUTH 61480-0255-05 · PLYMOUTH →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.